Diseases 2014, 2(1), 1-2; doi:10.3390/diseases2010001

Editorial
Diseases — the Reasons for a New Challenge in Open Access Medicine Research
Maurizio Battino
Dipartimento di Scienze Cliniche Specialistiche ed Odontostomatologiche, Sez-Biochimica, Faculty of Medicine, Università Politecnica delle Marche, Via Ranieri 65, 60100 Ancona, Italy; E-Mail: m.a.battino@univpm.it; Tel.: +39-071-220-4646; Fax: +39-071-220-4398
Received: 20 December 2013 / Accepted: 23 December 2013 / Published: 27 December 2013

First, I would like to warmly welcome the readers, contributors, and editorial board members of Diseases journal as a new entrant to the international periodicals industry.

The current offerings of scientific journals are very rich. One may wonder why there should be another journal, as well as what such a journal (Diseases) will be like.

Scientific topics (including medical ones) are multiplying quickly. When a multidisciplinary approach is required, existing journals often do not meet the resulting publishing needs. All medical topics’ publishing needs are quite sufficiently satisfied by (extremely) specialized journals. However, day by day, we are losing the holistic perspective that is often required to understand complex mechanisms. Also, the importance of reading and discussing different pathologies in the same journal/issue is, undoubtedly, not only a pleasure (or a brain work-out), but actually an enrichment for the readers (i.e., the investigators). If an open access journal devotes its efforts to these aims, the results can actually be intriguing; such an open access journal can reach a large community and involve said community in both the journal’s launch and in its development.

MDPI, which is now operating one of the most well-established, open-access publishing platforms, has never engaged before in such a challenge. Although MDPI is aware of the intrinsic difficulties of such a project, we now have the right colleagues to face the prospective challenges.

What will Diseases journal be like? This depends, to a large extent, on the inputs the Editors and Editorial Board will receive from both the contributors and the readers: on the one hand, the Editors will give as much space as possible to minor, but important, rare syndromes and conditions; on the other hand, there will be maximal alertness with respect to identifying conditions of increasing scientific interest on the basis of external warnings. Either molecular, biochemical or clinical approaches are welcome and papers applying an interdisciplinary approach will be the most welcome.

This periodicals project is arduously challenging and ambitious, but I am confident that the high level expertise of the Editorial Board Members and of all our reviewers, readers, and colleagues at MDPI will enable us to achieve our expected results.

I invite all of you to collaborate to help us make Diseases journal an important journal: your journal.

Diseases EISSN 2079-9721 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert